New Article now online: Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production https://t.co/Nr0gYBjeRU
Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Nov 2020 – May 2022Where it's discussed
-
News69 articles
-
X / Twitter45 posts
-
Facebook5 posts
-
Blogs5 articles
-
Reddit4 posts
-
YouTube2 videos
AI synopsis
What people are saying
The discussions across social discussions exemplify high agreement and engagement by highlighting findings that link short symptom duration with sustained immune responses, with language such as 'important implications' and 'excited to share' indicating both enthusiasm and perceived significance. Many posts cite specific results, like stable antibody levels correlating with quicker recovery, showing the deep engagement with the research details and potential impact on future immunity strategies.
Most discussions support the idea that certain patients recover quickly and sustain antibodies, emphasizing the importance of the study’s findings.
The social discussions show high interest, with many posts highlighting key aspects like antibody stability, recovery speed, and implications for immunity.
Posts reference detailed aspects of immune responses, mention multiple studies, and discuss clinical implications, indicating deep engagement.
Widespread sharing, detailed referencing, and expressions of excitement suggest that the publication could influence ongoing research and clinical practices.
Abstract in brief
- The study tracked antibody responses in 92 COVID-19 patients over time, finding that antibody levels vary widely and are generally higher with more severe symptoms.
- Most patients experienced a decline in IgG antibodies within 100 days, but a subgroup showed stable or increasing antibody levels, which was linked to faster recovery and specific immune features like higher memory B cell mutations and persistent activated CD4 T cells.
- These results suggest that quicker symptom resolution is associated with a more durable and effective immune response, highlighting differences in how individuals’ immune systems fight SARS-CoV-2.]
Top posts
Most liked on X and Bluesky(1/2) Excited to share our project (led by Yuezhou Chen, Adam Zuiani, & @duane_wesemann) on the longitudinal antibody response to SARS-CoV-2. So grateful for the opportunity to collaborate with all involved! @CellCellPress https://t.co/QRrfZzzGhu… https://t.co/vbHPIoIMcD
"Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production" - Read more from the study in @CellCellPress https://t.co/IozvQWrAoY https://t.co/11AnlIsWYd
Selon une étude sur 100 patients, une durée courte de symptômes du Covid-19 pourrait indiquer que l'immunité subsistante est de meilleure qualité que chez les patients avec durée de symptômes plus long. https://t.co/2PzOMsqrPe
Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production https://t.co/dou5aJcS9v
Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production https://t.co/sf1dSzziO4
All mentions
COVID-19 Update: Vaccine, Re-infections, and Food Safety Insights
Today, we provide a concise update addressing frequently asked questions about COVID-19. This video emphasizes the impact of the pandemic on food safety practices, highlighting the importance of hygiene in food handling…
COVID-19 Impact on Food Safety Practices and Regulations
This video discusses the impact of COVID-19 on food safety practices and regulations. It emphasizes the importance of maintaining hygiene and safe handling procedures in food production and distribution, highlighting…
SARS-CoV-2 antigen challenge histories in humans influence not only the speed and magnitude of antibody responses, but also functional cross-variant antibody repertoire composition and longevity @duane_wesemann @SciImmunology https://t.co/NsdlW8nCrY
@AbAnand9 @bulletmanV @Rita_Banerji @ha_realize @sanchak74 @drakchaurasia @AboutIndia @VMaya11156 @nicefiddler @R_MIG86 @WTF_1234567890A @GVDBossche @TOIIndiaNews Evidence : https://t.co/8YdSsm8ZZd
Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production: Cell https://t.co/GIFsO3yt7h
@Biomaven note to self: stable link Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production https://t.co/Y1fyabvMxr
新型コロナウイルスに対する抗体が維持するヒトの特徴について11月3日のCell誌に発表された。 #新型コロナウイルス #SARS_CoV_2 #抗体 #維持 #Cell (原題)Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production. https://t.co/kBY9v8cJ9j
Study uncovers subset of COVID-19 patients who recover quickly and sustain antibodies https://t.co/C2mTCESb8e https://t.co/bCfZz5HH38 https://t.co/oCM3wuNAjl
SARS-CoV-2の免疫抗体の持続性についての研究。 早期に回復した人は抗体が持続し強化、そうでない人は3-4ヶ月でなくなる、かも。ワクチンじゃないので注意。しかしワクチンも同様だと意味ない。 Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production https://t.co/CAm7P87X4F
Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production https://t.co/SzbGsytVyt
RT @CellPressNews: "Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production" - Read more from the study in @CellCellPress https:…
RT @CellPressNews: "Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production" - Read more from the study in @CellCellPress https:…
"Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production" - Read more from the study in @CellCellPress https://t.co/IozvQWrAoY https://t.co/11AnlIsWYd
While anti-spike protein IgG levels declined rapidly for most COVID-19 patients, those with sustained (and in some instances increased) anti-spike protein IgG levels experienced shorter disease course (median 10 vs. 16 days). https://t.co/NNOaVuGrF7
RT @ImmuneGC_Papers: GC | Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production. https://t.co/IAN6kcZ2eE
GC | Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production. https://t.co/IAN6kcZ2eE
RT @Fraslin: Selon une étude sur 100 patients, une durée courte de symptômes du Covid-19 pourrait indiquer que l'immunité subsistante est d…
RT @Fraslin: Selon une étude sur 100 patients, une durée courte de symptômes du Covid-19 pourrait indiquer que l'immunité subsistante est d…
RT @Fraslin: Selon une étude sur 100 patients, une durée courte de symptômes du Covid-19 pourrait indiquer que l'immunité subsistante est d…
Selon une étude sur 100 patients, une durée courte de symptômes du Covid-19 pourrait indiquer que l'immunité subsistante est de meilleure qualité que chez les patients avec durée de symptômes plus long. https://t.co/2PzOMsqrPe
RT @Krista_M_Pullen: (1/2) Excited to share our project (led by Yuezhou Chen, Adam Zuiani, & @duane_wesemann) on the longitudinal antibody…
RT @Krista_M_Pullen: (1/2) Excited to share our project (led by Yuezhou Chen, Adam Zuiani, & @duane_wesemann) on the longitudinal antibody…
Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production https://t.co/VUHHOFRWEw
RT @Krista_M_Pullen: (1/2) Excited to share our project (led by Yuezhou Chen, Adam Zuiani, & @duane_wesemann) on the longitudinal antibody…
RT @Krista_M_Pullen: (1/2) Excited to share our project (led by Yuezhou Chen, Adam Zuiani, & @duane_wesemann) on the longitudinal antibody…
RT @Krista_M_Pullen: (1/2) Excited to share our project (led by Yuezhou Chen, Adam Zuiani, & @duane_wesemann) on the longitudinal antibody…
(1/2) Excited to share our project (led by Yuezhou Chen, Adam Zuiani, & @duane_wesemann) on the longitudinal antibody response to SARS-CoV-2. So grateful for the opportunity to collaborate with all involved! @CellCellPress https://t.co/QRrfZzzGhu… https://t.co/vbHPIoIMcD
#CoronavirusGoodNews (4/4): See also: "Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production" By Duane Wesemann, et al. https://t.co/8RtSf0VQa8
Tomado de https://t.co/1H5aiJyY5g
Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production https://t.co/9LcykKnh6z
From @CellCellPress - Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production https://t.co/nsItMEvjzn #bwfpath
Quick COVID-19 healers sustain anti-SARS-CoV-2 antibody production https://t.co/LK1Jq1AVZZ via @docguide
Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production https://t.co/1QBUPdufIC
これが元論文(プレプリント)。“Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production“ https://t.co/7OVqBhWkIh
@spury2000 @physicianwomen @DrDenaGrayson @MtnMD @AndreaR9Md @DrLindaMD @feminemtweets @docrocktex26 @DrGJackBrown @meganranney @lipiroy @Craig_A_Spencer @darakass @choo_ek @DrLeanaWen @drnatalietv @VinGuptaMD @angie_rasmussen @chantler_jaki @DrEricDing @D__Fye Paper cited: Chen, Y et al. “Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production” Cell DOI:10.1016/j.cell.2020.10.051
Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production https://t.co/5dAxgAtzQ4
Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production https://t.co/a48bhsJFl2
Algunos pacientes, que se recuperan más rápidamente de la #COVID-19, presentan niveles de anticuerpos estables o crecientes frente al SARS-CoV-2
@julienpotet @__ice9 @farid__jalali I'm getting ahead of myself, but more great info in this new pre-print on extrafollicular vs germinal center refinement of antibody responses: https://t.co/MjZH4jxA7N
Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production https://t.co/dou5aJcS9v
RT @CellCellPress: New Article now online: Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production https://t.co/Nr0gYBjeRU
Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production https://t.co/sf1dSzziO4
RT @CellCellPress: New Article now online: Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production https://t.co/Nr0gYBjeRU
RT @CellCellPress: New Article now online: Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production https://t.co/Nr0gYBjeRU
RT @CellCellPress: New Article now online: Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production https://t.co/Nr0gYBjeRU
RT @CellCellPress: New Article now online: Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production https://t.co/Nr0gYBjeRU
New Article now online: Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production https://t.co/Nr0gYBjeRU